A new type of daily pill has proven more effective for weight loss and blood sugar control for people with type 2 diabetes than its currently available counterparts, according to a recent trial. The drug, known as orforglipron, could be a game-changer in the rapidly expanding oral weight-loss drug market. The advent of the injectable weight-loss drug semaglutide, known better by its brand names Wegovy (for weight loss) and Ozempic (for type 2 diabetes), marked a distinct […]

Read more

Geoff Bennett: The number of Americans taking GLP-1 drugs for weight loss is rising sharply. A new Gallup poll finds 11 percent of adults say they’re currently using one of the medications, up from just 3 percent two years ago. And that number could climb even higher now that Medicare has cleared the way for some patients to access these drugs, which can help reduce obesity substantially and the risk of other health problems. Our William Brangham […]

Read more

SUMMARY The number of Americans taking a GLP-1 drug for weight loss is on the rise. A new Gallup poll shows 11% of adults say they are currently using one, a dramatic increase from just two years ago when just 3% said they were using them. That number could climb even higher as Medicare has cleared the way for some patients to access the drugs. View the transcript of the story. NOTE: If you are short on […]

Read more

Published July 16, 2026 This is a summary of a story written by Shantell Kirkendoll on Duke University School of Medicine. Weight loss surgery has transformed lives for decades. Now, blockbuster GLP-1 drugs are accelerating that transformation and bringing a new challenge for plastic surgeons. New research from Duke University School of Medicine suggests that rapid weight loss, particularly when bariatric surgery is paired with GLP-1 medications, may increase risk of complications during body contouring procedures such […]

Read more

(NewsNation) — Eli Lilly says it now plans to seek FDA approval in early 2027 for its next-generation weight-loss drug, retatrutide, following positive results from two late-stage clinical trials. The drugmaker had previously indicated it could submit an application as early as 2026 for the weekly injectable treatment. According to Lilly, retatrutide works differently from other weight-loss medications currently on the market. In two Phase 3 trials, retatrutide produced significant weight loss and improvements in blood sugar […]

Read more

A beautiful, but over weight Maine Coon Cat gets measured around the belly by a vet. Ryersonclark | E+ | Getty Images Felix is five years old, loves food, and refuses to lose weight. His owner, Amy in Dallas, has tried cutting back on meals, but with two cats in the house, “he just gobbles down all the food,” she said. The extra pounds worry her because she knows obesity can shorten a cat’s life and strain […]

Read more

Listen to the article 6 min This audio is auto-generated. Please let us know if you have feedback. Eli Lilly is notching the most sales in the pharma industry, and is positioned to widen its lead over other Big Pharmas as it rides the wave of its GLP-1 obesity and diabetes drugs.  But the company is also making moves to maintain that top spot through an aggressive investment strategy to grow its drug portfolio, which could ultimately […]

Read more

Share this Article You are free to share this article under the Attribution 4.0 International license. People with severe obesity who exercise regularly have healthier blood vessels and lower inflammation than those who rely on medication alone, a new study shows. More and more people are living with severe obesity, and weight-loss medication is being used widely. But what does that mean for overall health beyond weight loss? A new study from the University of Copenhagen shows […]

Read more

Check out what’s clicking on FoxBusiness.com. Novo Nordisk sued Eli Lilly on Tuesday, accusing its rival of misleading consumers by claiming Lilly’s drugs work better than Novo’s competing treatments. The lawsuit, filed in federal court in New Jersey, argues that Lilly’s ads for Zepbound and Mounjaro compared the highest doses of its drugs with lower doses of Novo’s Wegovy and Ozempic. Novo said the ads rely on “outdated” trial data, according to Reuters. “The ads are maliciously […]

Read more

As many Americans continue to use weight loss drugs to treat type 2 diabetes and obesity, pharmacists and experts have warned about the potential risks of patient “undernutrition,” and have shared dietary guidance with Newsweek for those taking the drugs. GLP-1s like Ozempic and Wegovy have become increasingly popular, with one in eight Americans using them as of March 2026, according to data from Statista. The rise in their use has coincided with a decline in U.S. […]

Read more